Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Current Pharmaceutical Design
|
October 29, 2009
Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome
M Florentin, M S Elisaf, D P Mikhailidis, et al.
Current Medical Research and Opinion
|
February 23, 2008
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia
M Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Current Pharmaceutical Design
|
March 14, 2008
Fibrate-associated adverse effects beyond muscle and liver toxicity
M Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy
|
June 24, 2008
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes
M Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Clinical and Experimental Rheumatology
|
July 17, 2007
Persistent effect of zoledronic acid in Paget's disease
K Tziomalos, M Florentin, N Krikis, et al.
The Open Cardiovascular Medicine Journal
|
June 18, 2010
Fenofibrate in primary biliary cirrhosis: a pilot study
E N Liberopoulos, M Florentin, M S Elisaf, et al.
Current Vascular Pharmacology
|
February 26, 2010
Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension
E Moutzouri, M Florentin, M S Elisaf, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris
|
July 1, 1975
[Hearing disorders in children operated on for cleft palate]
J P Fombeur, M Florentin, D Seguin, et al.
Lipids
|
December 4, 2016
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study
M Florentin, M S Elisaf, C V Rizos, et al.
Expert Opinion on Pharmacotherapy
|
October 22, 2008
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study
M Florentin, E N Liberopoulos, T D Filippatos, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Current Pharmaceutical Design
|
October 29, 2009
Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome
M Florentin, M S Elisaf, D P Mikhailidis, et al.
Current Medical Research and Opinion
|
February 23, 2008
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia
M Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Current Pharmaceutical Design
|
March 14, 2008
Fibrate-associated adverse effects beyond muscle and liver toxicity
M Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Expert Opinion on Pharmacotherapy
|
June 24, 2008
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes
M Florentin, E N Liberopoulos, D P Mikhailidis, et al.
Clinical and Experimental Rheumatology
|
July 17, 2007
Persistent effect of zoledronic acid in Paget's disease
K Tziomalos, M Florentin, N Krikis, et al.
The Open Cardiovascular Medicine Journal
|
June 18, 2010
Fenofibrate in primary biliary cirrhosis: a pilot study
E N Liberopoulos, M Florentin, M S Elisaf, et al.
Current Vascular Pharmacology
|
February 26, 2010
Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension
E Moutzouri, M Florentin, M S Elisaf, et al.
Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris
|
July 1, 1975
[Hearing disorders in children operated on for cleft palate]
J P Fombeur, M Florentin, D Seguin, et al.
Lipids
|
December 4, 2016
L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study
M Florentin, M S Elisaf, C V Rizos, et al.
Expert Opinion on Pharmacotherapy
|
October 22, 2008
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study
M Florentin, E N Liberopoulos, T D Filippatos, et al.
Page
of 2